HomeInvestorsFinancial Results Financial Results Financial Results Corporate News Financial Calendar Investor Events Reports and Accounts Latest Financial Results Financial – 24 April 2024 – 1 mins read 24 April 2024 – 1 mins read LinkedIn Twitter Facebook Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance PARIS, FRANCE, 24 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Filter Period 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Filter by recent search Reset Showing: 1 – 05 of 27 Financial Results Show 05 10 20 30 40 50 Sort Ascending Descending Financial – 27 April 2022 27 April 2022 LinkedIn Twitter Facebook Ipsen delivers a strong sales performance in the first quarter of 2022 Attachment 3 related documents/links Q1 2022 – Sales announcement (333.10 KB) Q1 2022 – Sales presentation (1,014.94 KB) Q1 2022 – Webcast replay Financial – 11 February 2022 11 February 2022 LinkedIn Twitter Facebook Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business Attachment 3 related documents/links FY 2021 – Results announcement (856.59 KB) FY 2021 – Results presentation (2.17 MB) FY 2021 – Webcast replay Financial – 21 October 2021 21 October 2021 LinkedIn Twitter Facebook Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance 3 related documents/links YTD 2021 – Sales announcement (384.94 KB) YTD 2021 – Sales presentation (851.58 KB) YTD 2021 – Webcast replay Financial – 26 July 2021 26 July 2021 LinkedIn Twitter Facebook Ipsen delivers strong H1 2021 results and upgrades full-year guidance 3 related documents/links H1 2021 – Results announcement (637.85 KB) H1 2021 – Results presentation (3.32 MB) H1 2021 – Webcast replay Financial – 22 April 2021 22 April 2021 LinkedIn Twitter Facebook Ipsen delivers encouraging sales growth in the first quarter of 2021 despite the pandemic, and confirms its full-year guidance Attachment 3 related documents/links Q1 2021 – Sales announcement (217.51 KB) Q1 2021 – Sales presentation (736.46 KB) Q1 2021 – Webcast replay 1234…6 Your dedicated contacts Alina Levchuk Vice President, Investor Relations +41 795728712 Nicolas Bogler Senior Manager, Investor Relations +33 6 52 19 98 92